Carisma Therapeutics, Inc. (CARM )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol CARM
- Company Carisma Therapeutics, Inc.
- Price $0.05
- Changes Percentage 34.25
- Change 0.01
- Day Low $0.03
- Day High $0.07
- Year High $1.27
- Year Low $0.03
- Market Cap $2,047,617
- Price Avg 50 EMA (D) $0.24
- Price Avg 200 EMA (D) $0.32
- Exchange NASDAQ
- Volume 365,575
- Average Volume 9,038,987
- Open $0.03
- Previous Close $0.04
- EPS -1.19
- PE -0.04
- Earnings Announcement 2025-08-07 20:00:00
- Shares Outstanding $41,788,096
Company brief: CARISMA THERAPEUTICS, INC. (CARM )
- Healthcare
- Biotechnology
- Mr. Steven Kelly
- https://carismatx.com
- US
- N/A
- 02-06-2014
- US14216R1014
Carisma Therapeutics, Inc., a biopharmaceutical company, develops chimeric antigen receptors (CAR) macrophages for the treatment of solid tumors. Its solutions are used to play a crucial role in the innate and adaptive immune response, and technology leverages advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cellular therapy for the treatment of human diseases. Carisma Therapeutics, Inc. has a strategic collaboration agreement with Moderna Inc. Carisma Therapeutics, Inc. was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. The company was incorporated in 2016 and is based in Philadelphia, Pennsylvania.